about
The latex allergen Hev b 5 is an antigen with repetitive murine B-cell epitopesScaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)T Cell Epitope Peptide Therapy for Allergic DiseasesImmunoregulatory T cell epitope peptides: the new frontier in allergy therapyARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycleIgE Reactivity of Blue Swimmer Crab (Portunus pelagicus) Tropomyosin, Por p 1, and Other Allergens; Cross-Reactivity with Black Tiger Prawn and Effects of HeatingA novel grass pollen allergen mimotope identified by phage display peptide library inhibits allergen-human IgE antibody interaction.Molecular cloning, expression and immunological characterisation of Lol p 5C, a novel allergen isoform of rye grass pollen demonstrating high IgE reactivity.Use of phage display technology to investigate allergen-antibody interactions.Molecular cloning and characterization of hazel pollen protein (70 kD) as a luminal binding protein (BiP): a novel cross-reactive plant allergen.ADAM33 haplotypes are associated with asthma in a large Australian population.Characterization and de novo sequencing of snow crab tropomyosin enzymatic peptides by both electrospray ionization and matrix-assisted laser desorption ionization QqToF tandem mass spectrometry.Activin Biology After Lung TransplantationGalectin-10, a potential biomarker of eosinophilic airway inflammation.Prevalence of severe ant-venom allergy in southeastern Australia.Induction of allergic responses to peanut allergen in sheep.Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen).MHC class II expression in human basophils: induction and lack of functional significanceThe activin A antagonist follistatin inhibits cystic fibrosis-like lung inflammation and pathology.Substantial Increases Occur in Serum Activins and Follistatin during Lung Transplantation.Strategies for modulating immunoglobulin E synthesis.Impact of helminth infection on childhood allergic diseases in an area in transition from high to low infection burden.Effect of thermal processing on T cell reactivity of shellfish allergens - Discordance with IgE reactivityAdvances in development of hypoallergenic latex immunotherapy.The immunoregulatory and fibrotic roles of activin A in allergic asthmaThe use of nitrocellulose immunoblots for the analysis of antigen recognition by T lymphocytes.The peanut allergy epidemic: allergen molecular characterisation and prospects for specific therapy.Immunogenetic characteristics of immunoglobulin E in allergic disease.High Fat Diet Inhibits Dendritic Cell and T Cell Response to Allergens but Does Not Impair Inhalational Respiratory Tolerance.Latex allergy: a model for therapy.Egg provoked food protein-induced enterocolitis-like syndrome in an adult.Allergen-related approaches to immunotherapy.Tolerogenic dendritic cells derived from donors with natural rubber latex allergy modulate allergen-specific T-cell responses and IgE production.Shellfish allergy.Functional regulatory T cells and allergen immunotherapy.The roles of activin A and its binding protein, follistatin, in inflammation and tissue repair.Practical guide to skin prick tests in allergy to aeroallergens.Severe chronic allergic (and related) diseases: a uniform approach--a MeDALL--GA2LEN--ARIA position paper.Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs.The effects of engineered nanoparticles on pulmonary immune homeostasis.
P50
Q23912178-E837346F-9140-45FA-B0C5-E35444F3E2A5Q26740215-5E234903-087F-4643-B0F5-DEAA51686F00Q26771989-92879339-AFC8-47AF-A231-747A82A06F95Q26822702-E31C5FA5-F9E7-44C3-A2DB-169694860E41Q28355722-87128FE5-6334-4EBE-B87B-256AF761B7A1Q28384588-A29AF6FE-BE28-4681-A8A1-C3E02296E874Q30695207-8D081AFA-B4A2-4082-A012-802951632F59Q30830786-ED38F192-619F-416D-8BEA-36F97D5E446EQ31750586-3A8BB0FD-EBDA-4F90-8992-C9D1FE5495C2Q33187429-5525DCCC-BCE9-43D6-AF6D-C065BB68B599Q33246734-A2CD8DBF-7D36-4CD9-8216-183D97FE731AQ33536513-81154B28-4F3C-4658-A6C8-96D593059044Q33779046-522DEB3D-A952-41A8-B98E-46816C6EE569Q34374316-89BE4936-82AC-494C-BDB2-E6B870BEF704Q34454514-6A4D916B-D851-4FBC-9ED1-43C2009FA653Q34531827-AD4E8B55-C8BB-4C96-ABA2-FAF1BD165B11Q34589248-934ACA9F-7A5F-494B-A71A-F02C34C12E50Q35069773-B7FCB17F-B2EF-4296-8F1D-37E936C8EA6AQ35830783-6ADAC846-DAB4-4BDC-B142-BF1109F7E627Q35907211-8678FB32-F34F-4FD4-B70B-0DED47D67CD0Q35930863-C04065DB-1787-476E-BF00-71FC9884D421Q35937102-9434D706-D523-44A1-965E-710ABF4F3DAAQ36300878-756D5342-1C37-409B-BDE6-9774991B21A1Q36303730-A0A41CB8-7B1B-49F9-B3FF-2B3A4B1BBD17Q36393944-443803FC-7ED8-4661-8DF3-7140E2FD9C18Q36445483-DAB9A293-A5A4-4A38-B10C-44D6D75406B6Q36702194-02229C7A-C637-4B47-9370-EACA161DF0EAQ37080193-30BD1EC0-CF6E-425B-B6B5-65858965D999Q37146523-1F8D1337-6F40-4F14-8398-6C5F1393E517Q37171082-2BA896CC-C153-4DAD-844B-5D2F94996D35Q37247097-BDD0230B-2618-4492-9CB2-B251439A5574Q37359173-4104D47C-CD79-482B-9863-2A18B39121B5Q37505188-B894EE7F-75D4-48C7-933F-B0A9F98A499EQ37735882-1AE6C44C-2873-4438-A0B2-1A16DAC7F03BQ37790956-4046C6D0-766F-417E-B4BF-401B1DCE14E7Q37950790-FB2E3A5A-CB42-4AFA-94DE-926FA9986A55Q37952280-7E5DED39-71F9-48FF-98AA-63BF6A6EC410Q37989857-26B33AA7-5467-46CC-B9B9-C5569E664ADBQ38049856-025FFEA2-9068-4878-9243-215D2FCB3696Q38165210-CF5D4B90-884D-4A1B-B14C-E8A1FAEA741C
P50
description
immunologist and asthma researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Robyn E O'Hehir
@ast
Robyn E O'Hehir
@en
Robyn E O'Hehir
@es
Robyn E O'Hehir
@nl
Robyn E O'Hehir
@sl
type
label
Robyn E O'Hehir
@ast
Robyn E O'Hehir
@en
Robyn E O'Hehir
@es
Robyn E O'Hehir
@nl
Robyn E O'Hehir
@sl
altLabel
R E O'Hehir
@en
R E OHehir
@en
Robyn O'Hehir
@en
Robyn OHehir
@en
prefLabel
Robyn E O'Hehir
@ast
Robyn E O'Hehir
@en
Robyn E O'Hehir
@es
Robyn E O'Hehir
@nl
Robyn E O'Hehir
@sl
P1053
H-3627-2011
P1153
7005515688
P166
P21
P31
P3829
P496
0000-0002-3489-7595